{"product_id":"npc-ot2","title":"OT2","description":"\u0026lt;\u003cdetails open style=\"margin-top:30px; background:#05070A; border:1px solid #12343b; border-radius:18px; overflow:hidden; font-family:Arial,sans-serif;\"\u003e\n\n  \u003csummary style=\"padding:28px; cursor:pointer; color:#ffffff; font-size:26px; font-weight:900; letter-spacing:1px;\"\u003e\n    OT-Oxytocin Acetate Research Protocol\n  \u003c\/summary\u003e\n\n  \u003cdiv style=\"padding:32px; background:#0b1115; color:#c7d4d8; line-height:1.8;\"\u003e\n\n    \u003cp style=\"color:#7ed8e6; text-transform:uppercase; letter-spacing:3px; font-size:13px; margin:0 0 12px;\"\u003e\n      Northern Peptide Collective\n    \u003c\/p\u003e\n\n    \u003ch2 style=\"color:#ffffff; font-size:40px; margin:0 0 20px; line-height:1.1;\"\u003e\n      OT-Oxytocin Acetate\n    \u003c\/h2\u003e\n\n    \u003cp style=\"font-size:16px; color:#c7d4d8; line-height:1.9; margin-bottom:30px;\"\u003e\n      Research-focused information sheet covering Oxytocin Acetate pathway discussions,\n      neuro-signaling research, social-behavior pathway models, cognitive wellness discussions,\n      dosage references, stack information, FAQ, and laboratory documentation.\n    \u003c\/p\u003e\n\n    \u003cdiv style=\"\n      background:#111820;\n      border:1px solid #12343b;\n      border-radius:14px;\n      padding:18px 20px;\n      margin-bottom:30px;\n    \"\u003e\n\n      \u003cstrong style=\"\n        color:#00d9ff;\n        display:block;\n        margin-bottom:10px;\n        letter-spacing:1px;\n        text-transform:uppercase;\n        font-size:12px;\n      \"\u003e\n        Compound Reference\n      \u003c\/strong\u003e\n\n      \u003cp style=\"\n        margin:0;\n        color:#d8e3e8;\n        line-height:1.9;\n        font-size:15px;\n      \"\u003e\n        Oxytocin Acetate is commonly discussed in relation to\n        \u003cstrong style=\"color:#ffffff;\"\u003eneuro-signaling and social-behavior pathway research\u003c\/strong\u003e,\n        including mood-response discussions, trust and bonding models,\n        neurological signaling pathways, and central nervous system peptide research.\n      \u003c\/p\u003e\n\n    \u003c\/div\u003e\n\n    \u003cdiv style=\"display:grid; grid-template-columns:repeat(auto-fit,minmax(220px,1fr)); gap:18px; margin-bottom:35px;\"\u003e\n\n      \u003cdiv style=\"background:#111820; border:1px solid #12343b; border-radius:14px; padding:20px;\"\u003e\n        \u003cstrong style=\"color:#ffffff;\"\u003eResearch Category\u003c\/strong\u003e\n        \u003cp style=\"margin-bottom:0;\"\u003eNeurological \/ Behavioral Research\u003c\/p\u003e\n      \u003c\/div\u003e\n\n      \u003cdiv style=\"background:#111820; border:1px solid #12343b; border-radius:14px; padding:20px;\"\u003e\n        \u003cstrong style=\"color:#ffffff;\"\u003eCommon Range\u003c\/strong\u003e\n        \u003cp style=\"margin-bottom:0;\"\u003e10IU–40IU discussions\u003c\/p\u003e\n      \u003c\/div\u003e\n\n      \u003cdiv style=\"background:#111820; border:1px solid #12343b; border-radius:14px; padding:20px;\"\u003e\n        \u003cstrong style=\"color:#ffffff;\"\u003eFrequency\u003c\/strong\u003e\n        \u003cp style=\"margin-bottom:0;\"\u003eIntermittent protocol discussions\u003c\/p\u003e\n      \u003c\/div\u003e\n\n      \u003cdiv style=\"background:#111820; border:1px solid #12343b; border-radius:14px; padding:20px;\"\u003e\n        \u003cstrong style=\"color:#ffffff;\"\u003eResearch Window\u003c\/strong\u003e\n        \u003cp style=\"margin-bottom:0;\"\u003eProtocol dependent discussions\u003c\/p\u003e\n      \u003c\/div\u003e\n\n    \u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n\u003c\/details\u003e\n\n\u003cdetails style=\"margin-top:24px; background:#ffffff; border:1px solid #dde5e8; border-radius:18px; overflow:hidden; font-family:Arial,sans-serif;\"\u003e\n\n  \u003csummary style=\"padding:24px; cursor:pointer; font-size:24px; font-weight:900;\"\u003e\n    Compound Breakdown\n  \u003c\/summary\u003e\n\n  \u003cdiv style=\"padding:0 28px 28px; line-height:1.9; color:#334;\"\u003e\n\n    \u003ch3\u003eOxytocin Acetate\u003c\/h3\u003e\n\n    \u003cp\u003e\n      Oxytocin Acetate is commonly discussed in research involving neurological signaling,\n      behavioral pathway discussions, mood-response models,\n      and social interaction pathway research.\n    \u003c\/p\u003e\n\n    \u003cp\u003e\n      Research literature frequently references Oxytocin signaling in relation to\n      bonding discussions, stress-response pathways, emotional signaling models,\n      and central nervous system peptide activity.\n    \u003c\/p\u003e\n\n    \u003cp\u003e\n      Public discussions commonly involve neurobehavioral pathway models,\n      mood-response signaling, trust and connection discussions,\n      and neurological wellness research.\n    \u003c\/p\u003e\n\n  \u003c\/div\u003e\n\n\u003c\/details\u003e\n\n\u003cdetails style=\"margin-top:24px; background:#ffffff; border:1px solid #dde5e8; border-radius:18px; overflow:hidden; font-family:Arial,sans-serif;\"\u003e\n\n  \u003csummary style=\"padding:24px; cursor:pointer; font-size:24px; font-weight:900;\"\u003e\n    Wellness Focus\n  \u003c\/summary\u003e\n\n  \u003cdiv style=\"padding:0 28px 28px;\"\u003e\n\n    \u003cul style=\"line-height:2; color:#334;\"\u003e\n      \u003cli\u003eNeuro-signaling pathway research\u003c\/li\u003e\n      \u003cli\u003eBehavioral signaling discussions\u003c\/li\u003e\n      \u003cli\u003eSocial interaction pathway models\u003c\/li\u003e\n      \u003cli\u003eMood-response research\u003c\/li\u003e\n      \u003cli\u003eStress-response pathway discussions\u003c\/li\u003e\n      \u003cli\u003eNeurological wellness research\u003c\/li\u003e\n      \u003cli\u003eBonding and trust pathway discussions\u003c\/li\u003e\n      \u003cli\u003eCentral nervous system peptide models\u003c\/li\u003e\n    \u003c\/ul\u003e\n\n  \u003c\/div\u003e\n\n\u003c\/details\u003e\n\n\u003cdetails style=\"margin-top:24px; background:#05070A; border-radius:18px; overflow:hidden; font-family:Arial,sans-serif;\"\u003e\n\n  \u003csummary style=\"padding:24px; cursor:pointer; font-size:24px; font-weight:900; color:#ffffff;\"\u003e\n    Suggested Research Dosing Information\n  \u003c\/summary\u003e\n\n  \u003cdiv style=\"padding:0 28px 28px; color:#c7d4d8;\"\u003e\n\n    \u003ctable style=\"width:100%; border-collapse:collapse; margin-top:10px;\"\u003e\n\n      \u003ctr\u003e\n        \u003cth style=\"border:1px solid #12343b; padding:14px; text-align:left; color:#ffffff;\"\u003eProtocol Phase\u003c\/th\u003e\n        \u003cth style=\"border:1px solid #12343b; padding:14px; text-align:left; color:#ffffff;\"\u003eResearch Range\u003c\/th\u003e\n        \u003cth style=\"border:1px solid #12343b; padding:14px; text-align:left; color:#ffffff;\"\u003eNotes\u003c\/th\u003e\n      \u003c\/tr\u003e\n\n      \u003ctr\u003e\n        \u003ctd style=\"border:1px solid #12343b; padding:14px;\"\u003eIntroductory Discussion\u003c\/td\u003e\n        \u003ctd style=\"border:1px solid #12343b; padding:14px;\"\u003e10IU–20IU\u003c\/td\u003e\n        \u003ctd style=\"border:1px solid #12343b; padding:14px;\"\u003eInitial neurological pathway discussion\u003c\/td\u003e\n      \u003c\/tr\u003e\n\n      \u003ctr\u003e\n        \u003ctd style=\"border:1px solid #12343b; padding:14px;\"\u003eModerate Research\u003c\/td\u003e\n        \u003ctd style=\"border:1px solid #12343b; padding:14px;\"\u003e20IU–30IU\u003c\/td\u003e\n        \u003ctd style=\"border:1px solid #12343b; padding:14px;\"\u003eBehavioral signaling discussions\u003c\/td\u003e\n      \u003c\/tr\u003e\n\n      \u003ctr\u003e\n        \u003ctd style=\"border:1px solid #12343b; padding:14px;\"\u003eAdvanced Discussions\u003c\/td\u003e\n        \u003ctd style=\"border:1px solid #12343b; padding:14px;\"\u003e30IU–40IU\u003c\/td\u003e\n        \u003ctd style=\"border:1px solid #12343b; padding:14px;\"\u003eExtended pathway research models\u003c\/td\u003e\n      \u003c\/tr\u003e\n\n      \u003ctr\u003e\n        \u003ctd style=\"border:1px solid #12343b; padding:14px;\"\u003eFrequency Discussions\u003c\/td\u003e\n        \u003ctd style=\"border:1px solid #12343b; padding:14px;\"\u003eIntermittent structures\u003c\/td\u003e\n        \u003ctd style=\"border:1px solid #12343b; padding:14px;\"\u003eProtocol dependent discussions\u003c\/td\u003e\n      \u003c\/tr\u003e\n\n    \u003c\/table\u003e\n\n    \u003cp style=\"font-size:13px; color:#9daeb4; margin-top:18px; line-height:1.8;\"\u003e\n      Public peptide research discussions commonly reference Oxytocin Acetate\n      within intermittent neurological and behavioral pathway research structures.\n      Information presented is educational only and not medical guidance.\n    \u003c\/p\u003e\n\n  \u003c\/div\u003e\n\n\u003c\/details\u003e\n\n\u003cdetails style=\"margin-top:24px; background:#ffffff; border:1px solid #dde5e8; border-radius:18px; overflow:hidden; font-family:Arial,sans-serif;\"\u003e\n\n  \u003csummary style=\"padding:24px; cursor:pointer; font-size:24px; font-weight:900;\"\u003e\n    Reconstitution Reference\n  \u003c\/summary\u003e\n\n  \u003cdiv style=\"padding:0 28px 28px; color:#334; line-height:1.9;\"\u003e\n\n    \u003ctable style=\"width:100%; border-collapse:collapse;\"\u003e\n\n      \u003ctr\u003e\n        \u003cth style=\"border:1px solid #dde5e8; padding:14px; text-align:left;\"\u003eBAC Water\u003c\/th\u003e\n        \u003cth style=\"border:1px solid #dde5e8; padding:14px; text-align:left;\"\u003eApproximate Concentration Reference\u003c\/th\u003e\n      \u003c\/tr\u003e\n\n      \u003ctr\u003e\n        \u003ctd style=\"border:1px solid #dde5e8; padding:14px;\"\u003e1mL\u003c\/td\u003e\n        \u003ctd style=\"border:1px solid #dde5e8; padding:14px;\"\u003eHigher concentration preparation\u003c\/td\u003e\n      \u003c\/tr\u003e\n\n      \u003ctr\u003e\n        \u003ctd style=\"border:1px solid #dde5e8; padding:14px;\"\u003e2mL\u003c\/td\u003e\n        \u003ctd style=\"border:1px solid #dde5e8; padding:14px;\"\u003eBalanced concentration preparation\u003c\/td\u003e\n      \u003c\/tr\u003e\n\n      \u003ctr\u003e\n        \u003ctd style=\"border:1px solid #dde5e8; padding:14px;\"\u003e3mL\u003c\/td\u003e\n        \u003ctd style=\"border:1px solid #dde5e8; padding:14px;\"\u003eLower concentration \/ easier measurement reference\u003c\/td\u003e\n      \u003c\/tr\u003e\n\n    \u003c\/table\u003e\n\n  \u003c\/div\u003e\n\n\u003c\/details\u003e\n\n\u003cdetails style=\"margin-top:24px; background:#ffffff; border:1px solid #dde5e8; border-radius:18px; overflow:hidden; font-family:Arial,sans-serif;\"\u003e\n\n  \u003csummary style=\"padding:24px; cursor:pointer; font-size:24px; font-weight:900;\"\u003e\n    Stack Information\n  \u003c\/summary\u003e\n\n  \u003cdiv style=\"padding:0 28px 28px; color:#334; line-height:1.9;\"\u003e\n\n    \u003ch3\u003ePT-141\u003c\/h3\u003e\n    \u003cp\u003eFrequently discussed alongside neurological and behavioral signaling pathway discussions.\u003c\/p\u003e\n\n    \u003ch3\u003eSelank\u003c\/h3\u003e\n    \u003cp\u003eCommonly referenced in mood-response and calm-focus research models.\u003c\/p\u003e\n\n    \u003ch3\u003eSemax\u003c\/h3\u003e\n    \u003cp\u003eOften discussed in neuro-support and cognitive wellness research discussions.\u003c\/p\u003e\n\n    \u003ch3\u003eDSIP\u003c\/h3\u003e\n    \u003cp\u003eFrequently referenced in recovery and neurological wellness pathway discussions.\u003c\/p\u003e\n\n  \u003c\/div\u003e\n\n\u003c\/details\u003e\n\n\u003cdetails style=\"margin-top:24px; background:#ffffff; border:1px solid #dde5e8; border-radius:18px; overflow:hidden; font-family:Arial,sans-serif;\"\u003e\n\n  \u003csummary style=\"padding:24px; cursor:pointer; font-size:24px; font-weight:900;\"\u003e\n    Storage Information\n  \u003c\/summary\u003e\n\n  \u003cdiv style=\"padding:0 28px 28px; color:#334; line-height:1.9;\"\u003e\n\n    \u003ch3\u003eLyophilized \/ Unmixed\u003c\/h3\u003e\n\n    \u003cul\u003e\n      \u003cli\u003eStore frozen at approximately −20°C \/ −4°F.\u003c\/li\u003e\n      \u003cli\u003eProtect from direct light and moisture.\u003c\/li\u003e\n      \u003cli\u003eKeep sealed until laboratory preparation.\u003c\/li\u003e\n    \u003c\/ul\u003e\n\n    \u003ch3\u003eAfter Reconstitution\u003c\/h3\u003e\n\n    \u003cul\u003e\n      \u003cli\u003eRefrigerate at 2–8°C \/ 35–46°F.\u003c\/li\u003e\n      \u003cli\u003eAvoid repeated freeze-thaw cycles.\u003c\/li\u003e\n      \u003cli\u003eUse sterile laboratory handling practices.\u003c\/li\u003e\n      \u003cli\u003eStore protected from direct sunlight.\u003c\/li\u003e\n    \u003c\/ul\u003e\n\n  \u003c\/div\u003e\n\n\u003c\/details\u003e\n\n\u003cdetails style=\"margin-top:24px; background:#ffffff; border:1px solid #dde5e8; border-radius:18px; overflow:hidden; font-family:Arial,sans-serif;\"\u003e\n\n  \u003csummary style=\"padding:24px; cursor:pointer; font-size:24px; font-weight:900;\"\u003e\n    Educational Visuals \u0026amp; Research Notes\n  \u003c\/summary\u003e\n\n  \u003cdiv style=\"padding:0 28px 28px; color:#334; line-height:1.9;\"\u003e\n\n    \u003cp\u003e\n      OT-Oxytocin Acetate is frequently referenced in neuro-signaling pathway discussions,\n      behavioral signaling research, mood-response pathway models,\n      and central nervous system peptide investigations.\n    \u003c\/p\u003e\n\n    \u003cp\u003e\n      Research communities commonly discuss Oxytocin signaling in relation to\n      trust and bonding pathways, stress-response discussions,\n      neurological wellness models, and behavioral signaling research.\n    \u003c\/p\u003e\n\n    \u003cp\u003e\n      Current publicly discussed applications remain experimental and research-focused.\n    \u003c\/p\u003e\n\n  \u003c\/div\u003e\n\n\u003c\/details\u003e\n\n\u003cdetails style=\"margin-top:24px; background:#ffffff; border:1px solid #dde5e8; border-radius:18px; overflow:hidden; font-family:Arial,sans-serif;\"\u003e\n\n  \u003csummary style=\"padding:24px; cursor:pointer; font-size:24px; font-weight:900;\"\u003e\n    Frequently Asked Questions\n  \u003c\/summary\u003e\n\n  \u003cdiv style=\"padding:0 28px 28px; color:#334; line-height:1.9;\"\u003e\n\n    \u003cp\u003e\n      \u003cstrong\u003eWhat is OT-Oxytocin Acetate commonly researched for?\u003c\/strong\u003e\u003cbr\u003e\n      Neuro-signaling pathway discussions, behavioral signaling research,\n      mood-response pathway models, and social interaction research.\n    \u003c\/p\u003e\n\n    \u003cp\u003e\n      \u003cstrong\u003eWhat type of peptide is Oxytocin Acetate?\u003c\/strong\u003e\u003cbr\u003e\n      Oxytocin Acetate is commonly discussed as a neuropeptide associated with\n      central nervous system and behavioral signaling pathways.\n    \u003c\/p\u003e\n\n    \u003cp\u003e\n      \u003cstrong\u003eWhat pathways are commonly associated with Oxytocin research?\u003c\/strong\u003e\u003cbr\u003e\n      Social signaling discussions, bonding pathway models,\n      stress-response signaling, and neurobehavioral pathway research.\n    \u003c\/p\u003e\n\n    \u003cp\u003e\n      \u003cstrong\u003eWhat compounds are commonly discussed with Oxytocin Acetate?\u003c\/strong\u003e\u003cbr\u003e\n      PT-141, Selank, Semax, and DSIP are frequently referenced in neurological and behavioral pathway discussions.\n    \u003c\/p\u003e\n\n    \u003cp\u003e\n      \u003cstrong\u003eIs OT-Oxytocin Acetate intended for human consumption?\u003c\/strong\u003e\u003cbr\u003e\n      No. OT-Oxytocin Acetate is intended strictly for laboratory and educational research reference purposes only.\n    \u003c\/p\u003e\n\n  \u003c\/div\u003e\n\n\u003c\/details\u003e\n\n\u003cdiv style=\"margin-top:24px; background:#05070A; padding:34px; border-radius:18px; text-align:center; font-family:Arial,sans-serif;\"\u003e\n\n  \u003ch2 style=\"color:#ffffff; margin-top:0;\"\u003e\n    COA \u0026amp; Documentation\n  \u003c\/h2\u003e\n\n  \u003cp style=\"color:#c7d4d8; line-height:1.8;\"\u003e\n    View batch documentation, laboratory information, and product verification.\n  \u003c\/p\u003e\n\n  \u003ca href=\"PASTE_COA_LINK_HERE\" target=\"_blank\" style=\"\n      background:#00d9ff;\n      color:#05070A;\n      padding:16px 34px;\n      border-radius:10px;\n      text-decoration:none;\n      font-weight:bold;\n      display:inline-block;\n      letter-spacing:1px;\n     \"\u003e\n    VIEW COA DOCUMENT\n  \u003c\/a\u003e\n\n\u003c\/div\u003e\n\n\u003cdiv style=\"margin-top:24px; background:#fff3cd; border:1px solid #ffe08a; padding:22px; border-radius:14px; font-size:13px; line-height:1.8; font-family:Arial,sans-serif;\"\u003e\n\n  \u003cstrong\u003eImportant Notice:\u003c\/strong\u003e\n\n  This information is intended strictly for laboratory and educational research reference purposes only.\n  Not approved for human consumption, medical use, diagnosis, treatment, or prevention of disease.\n\n\u003c\/div\u003e","brand":"Northern Peptide Collective","offers":[{"title":"OT2-SINGLE \/ 2mg x 10vials","offer_id":47956718256302,"sku":"OT2-SINGLE","price":45.0,"currency_code":"CAD","in_stock":true},{"title":"OT2-10PACK \/ 2mg x 10vials","offer_id":47956718289070,"sku":"OT2-10PACK","price":270.0,"currency_code":"CAD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0750\/4707\/6014\/files\/1c845c67-9f7d-4d69-a50c-82083118b8a2.png?v=1780848375","url":"https:\/\/northernpeptidecollective.ca\/products\/npc-ot2","provider":"Northern Peptide Collective","version":"1.0","type":"link"}